You searched for viral vector - Page 28 of 53

News and Trends 17 Mar 2023

Beyond Biotech podcast 38: Hello Tomorrow Global Summit

…in unwanted tissues in cases of vector biodistribution through a Double Lock Safety system – tissue-specific vector modifications (first lock) combined with Hele-GUIDE tissue specific guide RNA (second lock) for…

March 17, 2023 - 3 minutesmins - By Jim Cornall

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed…

August 19, 2021 - 3 minutesmins - By Victor Kotsev

Best in Biotech 16 Jan 2025

Ten first-in-class drugs on track for FDA approval in 2025

…adeno-associated virus (AAV9) vector. By introducing a functional copy of the I2S gene into CNS cells, RGX-121 aims to restore the production of the I2S enzyme, enabling the breakdown of…

January 16, 2025 - 13 minutesmins - By Jules Adam

News and Trends 7 Dec 2022

Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy

…vector technology, providing the company with a clinical supply of personalized dbDNA, to support and underpin the development of their candidate immunotherapy cancer treatment. The program is expected to start…

December 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 18 Apr 2016

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

…Society). GenSight’s gene therapy works by insertion of a functioning gene, delivered by Adeno-associated viral (AAV) vector to replace the faulty protein (Credit: GenSight) So you just announced a new…

April 18, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 15 Dec 2022

EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation

…reduced fees for regulatory activities, and 10 years of market exclusivity in the EU upon drug approval. rAAV-Olig001-ASPA is a novel vector from a class of recombinant AAVs (rAAVs) that…

December 15, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Jul 2021

The Top European Biotech Funding Rounds in June

…the gene therapy firm VectorY Therapeutics, which raised an oversized seed round in the Netherlands. VectorY aims to treat muscular and neurodegenerative conditions by delivering to the patient’s cells genetic…

July 8, 2021 - 5 minutesmins - By Jonathan Smith

In Depth 7 Dec 2023

The biggest private biotech investments in November 2023

The companies Cambrian Innovation, Terremoto Biosciences, and VectorY Therapeutics bagged the biggest biotech investments in November 2023. Around the world, oncology and central nervous system players attracted the biggest funding…

December 7, 2023 - 3 minutesmins - By Willow Shah-Neville

In Depth 25 Apr 2024

What are biotech companies doing to tackle malaria?

…still something to strive for, biotechs are working towards treatment measures and vector control strategies to drastically reduce the incidence of the disease. As we observe World Malaria Day on…

April 25, 2024 - 13 minutesmins - By Roohi Mariam Peter

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

…manufacture, and commercialize in vivo gene editing therapies delivered with engineered AAV vectors for the treatment of familial ALS and Friedreich’s ataxia. Additionally, in early 2023, Capsida announced another strategic…

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

Interview 4 Sep 2019

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

…the chikungunya virus are expanding their range. This is largely due to climate change, which is making southern regions of Europe hotter and more hospitable for insect disease vectors such…

September 4, 2019 - 9 minutesmins - By Jonathan Smith

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

…the arm that invested in Exscientia’s Series C and it has invested in expanding companies such as UK-based Oxford Biomedica, which specializes in developing lentiviral vectors for cell and gene…

May 29, 2020 - 3 minutesmins - By David Kirk

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Beyond Biotech podcast 38: Hello Tomorrow Global Summit

Chikungunya Vaccine First to Succeed in Phase III Trial

Ten first-in-class drugs on track for FDA approval in 2025

Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation

The Top European Biotech Funding Rounds in June

The biggest private biotech investments in November 2023

What are biotech companies doing to tackle malaria?

10 neuroscience biotech companies you should know about

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

AI Drug Discovery Firm Exscientia Closes €54M Series C

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!